Neurocrine Biosciences (NASDAQ: NBIX) is a biopharmaceutical company that develops and commercializes medicines for neurological and endocrine-related diseases. The filing excerpts provided do not contain sufficient detail to describe specific revenue figures, product names, segment breakdowns, market position, or other business specifics for FY2025. The 10-K was filed on 2026-02-11 under accession number 000091447526000007, but the substantive business, financial, and product content from the filing was not included in the excerpts made available for this summary. A complete description will require access to the full Item 1 Business section and financial statements from that filing.

Source: SEC 10-K, filed 2026-02-11

Industry: Biological Products, (No Diagnostic Substances) Peers: Alnylam Pharmaceuticals Inc Sarepta Therapeutics Inc Apellis Pharmaceuticals Inc Biohaven Pharmaceutical Holding Co Ltd. BioMarin Pharmaceutical Inc Incyte Corp Karuna Therapeutics, Inc. Seagen Inc. United Therapeutics Corp